• MediciNova Announces Positive Clinical Results Regarding MN-166 for Prevention of Chemotherapy-induced Peripheral Neuropathy Published in Cancer Chemotherapy and Pharmacology

    27 days ago - By San Diego Biotechnology

    LA JOLLA, Calif., Sept. 24, 2020 - MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market and the JASDAQ Market of the Tokyo Stock Exchange , today announced positive clinic......
    Read more ...